Provision of Clinical Laboratory Services - Molecular Pathology Diagnostic Services (PD-L1 Testing Service)
Description: County Durham and Darlington NHS Foundation Trust (CDDFT) have a requirement for PD-L1 testing services. The services are essential to maintaining continuity of patient care, meeting statutory and regulatory obligations, and ensuring that clinical teams have access to accurate and reliable test results to inform treatment decisions.
Summary: The County Durham and Darlington NHS Foundation Trust (CDDFT) has concluded a tender process for the provision of Clinical Laboratory Services focusing on Molecular Pathology Diagnostic Services, specifically PD-L1 Testing Services. The procurement falls under the services category and was carried out through a direct award process, compliant with the Health Care Services (Provider Selection Regime) Regulations 2023. This process culminated in an award to University Hospitals Birmingham NHS Foundation Trust. The contract, valued at £131,871.11, is set to commence on 1st July 2026 for a duration of 33 months, with the potential for extension by up to 24 additional months. Located in the North East of England (UKC region), this procurement stage is now at the award phase, formalised on 1st July 2026.